CLINICAL_TRIALS
trial_result
· 2022-05-02
Clinical Trial Update: Liposome Bupivacaine Interscalene Total Shoulder [Phase 2]
Summary
Phase 2 clinical trial evaluating liposome bupivacaine for interscalene total shoulder analgesia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Acute Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-05-02